The civic record
Read. Follow. Verify.Georgia House Bill 373 requires health insurance coverage for annual prostate cancer screenings for high-risk…
Last action · March 3, 2025: Senate Read and ReferredSponsors: Lydia Glaize and 5 others
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
What This Bill Proposed
Georgia health benefit policies must cover annual prostate cancer screenings, including digital rectal examinations and s, for high-risk men starting January 1, 2026. High-risk individuals include men aged 50 and older, men aged 40 to 49 with a family history of prostate cancer, and others designated by a physician.
Insured residents meeting specific age or family-history criteria gain guaranteed coverage for annual s and digital rectal examinations without specified cost-sharing exclusions.
Who It Would Have Affected
Groups the bill's text would have affected, as described in the record. Being affected is not a position for or against it.
men with a high risk for prostate cancer
Eligible policyholders gain guaranteed health insurance coverage for annual prostate-specific antigen tests and digital rectal examinations.
health benefit insurers
Insurers must update their health benefit policies to provide and pay for annual prostate cancer screenings for qualifying enrollees.
Key Facts
- Health benefit policies must provide coverage for annual prostate cancer screenings for high-risk men beginning January 1, 2026.
- Mandated screening coverage must include both a digital rectal examination and a prostate-specific antigen test.
- High-risk men include individuals aged 50 and older.
- High-risk men include individuals aged 40 to 49 with a family history of prostate cancer.
Show all 7 facts
- High-risk men include other individuals determined to be at risk by a physician.
- Family history includes a first-degree relative diagnosed with, affected by, or deceased from prostate cancer or associated cancers, or possessing a related genetic alteration.
- The requirements apply to policies issued, delivered, issued for delivery, or renewed on or after January 1, 2026.
Frequently Asked Questions
Who qualifies as having a high risk for prostate cancer under this bill?
What specific tests are covered under the mandate?
What else do you want to know?
News Coverage
Follow the record
Votes, people, money & the original sourceWhere This Stands
This bill did not become law - Died at adjournment · passed the House · in the Senate.
Procedural history
7 actions- Mar 3, 2025SenateIntroducedSenate Read and Referred
- Feb 28, 2025HouseHouse Third Readers
- Feb 28, 2025HouseFloorHouse Passed/Adopted By Substitute
- Feb 26, 2025HouseCommitteeHouse Committee Favorably Reported By Substitute
- Feb 12, 2025HouseHouse Second Readers
- Feb 11, 2025HouseIntroducedHouse First Readers
Show 1 earlier action
- Feb 10, 2025HouseIntroducedHouse Hopper
Version history & redline
3 versions on fileVoting Record
PASSAGE
Total
174
- Yes
- 160
- No
- 1
- Present
- 0
- Not voting
- 5
- Abstain
- 0
- Other positions
- 8
How they voted (174)
150 more members
Lobbying Activity
No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.
Full breakdown
Who this bill affects and the strongest case for and against it, written only from the bill’s own text.
Sponsors
Show 1 more sponsor
Connected Entities
Sources
www.legis.ga.gov
Analysis Score
0–100- Significance20Lowered because this bill did not pass (its text scored 65)
- Controversy15Intensity of disagreement among stakeholders
- Entertainment5Compellingness for a non-policy-wonk reader
- Buzz30Current news / social attention level
Publisher tools
